The MMA reiterates that commercial interest must never supersede patient safety and quality of care. Vaccination is not a transaction — it is a clinical act that carries accountability, responsibility, and duty of care.
MMA denounces a TPA's directive to panel hospitals on the choice of anaesthesia (LA over GA) and the classification of certain procedures as daycare/inpatient as interference in clinical autonomy and a breach of medical ethics. MMA demands action from MOH.
DRSFORALL condemns MediExpress' local anaesthesia (LA)-first policy for panel hospitals as unacceptable interference with clinical practice that endangers patients and exposes doctors/hospitals to medico-legal liability. It's also unlawful under Act 586.
DRSforALL tells CAP and its allies to set their priorities straight instead of attacking GPs that have "long served as a critical pillar of Malaysia's community health care system". Among others, GPs pioneered community-based heroin addiction treatment.
MMA questions using the Price Control and Anti-Profiteering Act 2011 to regulate private clinics already under the Private Healthcare Facilities and Services Act 1998. It says GPs aren’t retailers but prescribe and sell meds only after consultation.
Association of Private Practitioners Sabah immediate past president Dr James Jeremiah urges MOH to tailor CKAPS regulations to accommodate the unique challenges faced by GP clinics in Sabah, streamline licensing processes, and adjust GP consultation rates.
APHM Factbook 2024 highlights regulatory burdens on private hospitals in a "bureaucratic maze", including approvals from at least 10 agencies. Single-specialty hospitals face significant challenges. Overlapping regulations cause delays and increase costs.
The Health parliament committee demands "standardised" charges for medical treatments to address disparities in private hospital bills, urging the fast-tracking of DRG payment models. They also support Bank Negara's copayment mandate for health insurance.
GP clinics are declining into a "sunset industry", says FPMPAM, "strangled" by mounting regulatory burdens like drug price displays, while doctor fees stagnate and TPAs grow. "There are too many regulations. They are killing the practice of medicine."